Results 21 to 30 of about 15,899 (181)
All information of BioSamples from isolates harboring carbapenemases.
, 2023 All information of BioSamples from isolates harboring carbapenemases.
Yeganeh Malek Mohammadi (17403594) +4 more
core +1 more source
Panorama of carbapenemases in Peru
, 2020 Objective. To describe the genotypes of the carbapenemases reported from microbiological isolates of patients in Peru. Methods. A systematic search of the biomedical literature about carbapenemases with genotypic confirmation was carried out. It included
Sacsaquispe-Contreras, R. +3 more
core +1 more source
The “hidden” carbapenemase of Aeromonas hydrophila [PDF]
Journal of Antimicrobial Chemotherapy, 1996 It has been presumed that there are just two beta-lactamases in the motile Aeromonas species, a carbapenemase and a cephalosporinase, based on the premise that all beta-lactamases can be detected by hydrolysis of the chromogenic cephalosporin, nitrocefin.
M V, Hayes, C J, Thomson, S G, Amyes
openaire +2 more sources
Number of detected peptides from (potential) β lactamases or carbapenemases.
, 2023 Number of detected peptides from (potential) β lactamases or carbapenemases.
Holger C. Scholz (9118844) +5 more
core +1 more source
Detection of carbapenemase production in Enterobacteriaceae and Pseudomonas species by carbapenemase Nordmann–Poirel test [PDF]
Journal of Laboratory Physicians, 2019 Abstract PURPOSE: Multidrug-resistant organisms causing community-acquired and hospital-acquired infections are increasing at a dangerous rate. Carbapenemase-producing Enterobacteriaceae and Pseudomonas species are an important source of concern since these organisms are not only resistant to beta-lactam antibiotics but also show cross ...
Rao, Morubagal R. +5 more
openaire +2 more sources
The Immaculate Carbapenemase Study [PDF]
Journal of Clinical Microbiology, 2017 ABSTRACT Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and are typically resistant to most (sometimes all) antibiotics. We now face a global CPO pandemic of high mortality. In this issue of the Journal of Clinical Microbiology , Karlowsky
openaire +2 more sources
Structural and Functional Aspects of Class A Carbapenemases. [PDF]
, 2016 The fight against infectious diseases is probably one of the greatest public health challenges faced by our society, especially with the emergence of carbapenem-resistant gram-negatives that are in some cases pan-drug resistant.
Dortet, L +5 more
core +1 more source
Carbapenemases on the move: it’s good to be on ICEs [PDF]
Mobile DNA, 2018 Abstract The evolution and spread of antibiotic resistance is often mediated by mobile geneticelements. Integrative and conjugative elements (ICEs) are the most abundant conjugativeelements among prokaryotes. However, the contribution of ICEs to horizontal gene transferof antibiotic resistance has been largely ...
João Botelho +4 more
openaire +5 more sources
Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae [PDF]
Antimicrobial Stewardship & Healthcare Epidemiology, 2021 Background: Carbapenem-resistant Enterobacteriaceae (CRE) remain among the most urgent infectious threats according to the CDC Threats Reports. Although focus has often been placed on carbapenemase-producing phenotypes, there is increasing interest in distinguishing the optimal treatment and outcomes of carbapenemase-producing (CP) and non ...
Clark, Justin, Burgess, David
openaire +1 more source
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases [PDF]
, 2021 Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere. Because P. aeruginosa readily mutate to become carbapenem resistant via loss of
Vickers, Anna +4 more
core +1 more source